PPARA and cancer: The PI3K/AKT/mTOR pathway is activated by CD147 to up-regulate HIF-1α-mediated glycolysis, and CD147 inhibits PPARα-mediated FAO by activating the MAPK pathway, which eventually leads to drug resistance in cancer cells [86].